Trial Profile

A Phase 1, Four-Week, Randomized, Double-Blind, Dose-Finding, Placebo-Controlled, Single Center, Cosmetic Clinical Study to Evaluate the Safety and Tolerability of BX001 in Individuals with Mild-to-Moderate Acne

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 02 Apr 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

31 Mar 2020 According to a BiomX media release, the company will host an investor conference call today at 8:00 a.m. ET to discuss the results of this trial.
31 Mar 2020 Results presented in the BiomX Media Release.
03 Feb 2020 According to a BiomX media release, the company looks forward to disclosing the data from this study by the end of the first quarter of 2020.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com